Positioning about the flexibility of fasting for lipid profiling;Posicionamento sobre a Flexibilização do Jejum para o Perfil Lipídico

Arquivos Brasileiros de Cardiologia

Volumn 108, Issue 3, 2017, Pages 195-197

  Scartezini, Marileia ^a   Ferreira, Carlos Eduardo dos Santos ^b   Izar, Maria Cristina Oliveira ^c   Bertoluci, Marcello ^d   Vencio, Sergio ^e   Campana, Gustavo Aguiar ^b   Sumita, Nairo Massakazu ^b   Barcelos, Luiz Fernando ^a   Faludi, André A ^c   Santos, Raul D ^c   Malachias, Marcus Vinícius Bolívar ^c   Aquino, Jerolino Lopes ^a   Galoro, César Alex de Oliveira ^b   Sabino, Cleide ^d   Gurgel, Maria Helane Costa ^d   Turatti, Luiz Alberto Andreotti ^e   Hohl, Alexandre ^d   Martinez, Tania Leme da Rocha ^c  

^a Sociedade Brasileira de Análises Clínicas SBAC   (Brazil)

^b Medicina Laboratorial SBPC ML   (Brazil)

^c Sociedade Brasileira de Cardiologia   (Brazil)

^d Sociedade Brasileira de Endocrinologia e Metabologia   (Brazil)

^e Sociedade Brasileira de Anestesiologia   (Brazil)

Author keywords

Fasting metabolism; Lipid profile; Postprandial; Reference values; Risk category

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; AMPUTATION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DIET RESTRICTION; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOGLYCEMIA; LIPID ANALYSIS; POSTPRANDIAL STATE; REFERENCE VALUE; RISK ASSESSMENT; BLOOD; BRAZIL; PRACTICE GUIDELINE; STANDARD; TIME FACTOR;

BRAZIL; CHOLESTEROL; FASTING; HUMANS; POSTPRANDIAL PERIOD; REFERENCE STANDARDS; REFERENCE VALUES; TIME FACTORS; TRIGLYCERIDES;

EID: 85018702051     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20170039     Document Type: Article

References (16)

1. Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert R, et al; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58.
2. Driver SL, Martin SS, Gluckman TJ, Clary JM, Blumenthal RS, Stone NJ. Fasting or nonfasting lipid measurements. it depends on the question. J Am Coll Cardiol. 2016;67(10):1227-34.
3. Rifai N, Young IS, Nordestgaard BG, Wierzbicki AS, Vesper H, Mora S, et al. Nonfasting sample for the determination of routine lipid profile: is it an idea whose time has come? Clin Chem. 2016;62(3):428-35.
4. Langsted A, Nordestgaard BG. Nonfasting lipid profiles: the way of the future. Clin Chem. 2015;61(9):1123-5.
5. Doran B, Guo Y, Xu J, Weintraub H, Mora S, Maron DJ, et al. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014; 130 (7): 546-53.
6. Sabaka P, Kruzliak P, Gaspar L, Caprnda M, Bendzala M, Balaz D, et al. Postprandial changes of lipoprotein profile: effect of abdominal obesity. Lipids Health Dis. 2013;12:179.
7. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a cross-sectional study. Arch Intern Med. 2012;172(22):1707-10.
8. Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387-97.
9. Xavier HT. Izar MC, Faria Neto JR, Assad MH, Rocha VZ, Sposito AC, et al; Sociedade Brasileira de Cardiologia. [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis]. Arq Bras Cardiol. 2013;101(4 Suppl 1):1-20.
10. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart Lung and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 Suppl 5:S213-56.
11. Steiner MJ, Skinner AC, Perrin EM. Fasting might not be necessary before lipid screening: A Nationally Representative Cross-sectional Study. Pediatrics. 2011;128(3):463-70.
12. Cholesterol Treatment Trialist (CTT) Collaborators: Efficacy of cholesterol lowering therapy in 18.686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117–125.
13. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, CARDS investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicenter randomized placebo-controlled trial. Lancet 2004; 364 (9435):685–696.
14. Nordestgaard BG, Chapman MJ, Humphri es SE, Gi nsberg HN, Masana L, Descamps OS et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. European Heart Journal. 2013; 34 (45): 3478-90.
15. Friedewald WT, Lavy RI, Fredrickson DS. Estimation to density lipoprotein without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013; 310(19): 2061-681.